GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » YoY Rev. per Sh. Growth

Cytophage Technologies (TSXV:CYTO) YoY Rev. per Sh. Growth : 0.00% (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Cytophage Technologies's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 was 0.00%.

Cytophage Technologies's Revenue per Share for the three months ended in Mar. 2024 was C$0.00.


Cytophage Technologies YoY Rev. per Sh. Growth Historical Data

The historical data trend for Cytophage Technologies's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies YoY Rev. per Sh. Growth Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
- - -

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial - - - - -

Cytophage Technologies YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Cytophage Technologies's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(0-0)/ | 0 |
=N/A %

Cytophage Technologies's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2024 )
=(Revenue per Share (Q: Mar. 2024 )-Revenue per Share (Q: Dec. 2022 )) / | Revenue per Share (Q: Dec. 2022 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cytophage Technologies YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytophage Technologies (TSXV:CYTO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.

Cytophage Technologies (TSXV:CYTO) Headlines

From GuruFocus

Altamira Therapeutics Announces Reverse Stock Split

By Value_Insider Value_Insider 10-24-2022

Altamira Therapeutics Provides Update on Clinical Trials with Bentrio

By Stock market mentor Stock market mentor 01-24-2023

Altamira Therapeutics Provides Year-End 2022 Business Update

By Value_Insider Value_Insider 12-19-2022